Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials (Q1727847): Difference between revisions

@@ Property / DOI @@
-.1016/j.csda.2018.06.015
@@ Property / DOI: 10.1016/j.csda.2018.06.015 / rank @@
-Normal rank
@@ Property / cites work @@
+Q4293547
@@ Property / cites work: Q4293547 / rank @@
+Normal rank
@@ Property / cites work @@
+Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials
+Normal rank
@@ Property / cites work @@
+Bivariate Sequential Designs for Phase II Trials
@@ Property / cites work: Bivariate Sequential Designs for Phase II Trials / rank @@
+Normal rank
@@ Property / cites work @@
+Designs for Phase II Trials Allowing for a Trade-Off between Response and Toxicity
+Normal rank
@@ Property / cites work @@
+Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials
+Normal rank
@@ Property / cites work @@
+Bayesian two-stage design for phase II clinical trials with switching hypothesis tests
+Normal rank
@@ Property / cites work @@
+Incorporating Bayesian ideas into health-care evaluation
+Normal rank
@@ Property / cites work @@
+Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes
+Normal rank
@@ Property / cites work @@
+Practical Bayesian Guidelines for Phase IIB Clinical Trials
+Normal rank
@@ Property / Wikidata QID @@
+Q129575119
@@ Property / Wikidata QID: Q129575119 / rank @@
+Normal rank
@@ Property / DOI @@
+.1016/J.CSDA.2018.06.015
@@ Property / DOI: 10.1016/J.CSDA.2018.06.015 / rank @@
+Normal rank